Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Meet with our team to discuss your goals and health history
Catastrophic ATP loss underlies a metabolic combination therapy tailored for MYCN -amplified neuroblastoma
The strength of the promoter in transgene therapy or modulation of the CRISPRa transcriptional activators will play a key role in determining the appropriate treatment and avoiding unpredictable or undesired treatment consequences
Impact of 30-day oral dosing with N-acetyl-L-cysteine on Sprague-Dawley rat physiology
US$ 23.17
US$ 22.43
US$ 27.47
US$ 28.34
US$ 20.14
US$ 22.12
US$ 25.11
US$ 26.53
US$ 26.34
